Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avalon GloboCare (ALBT) Research & Development (2018 - 2023)

Historic Research & Development for Avalon GloboCare (ALBT) over the last 6 years, with Q4 2023 value amounting to -$542.0.

  • Avalon GloboCare's Research & Development fell 10028.56% to -$542.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $109618.0, marking a year-over-year decrease of 8501.11%. This contributed to the annual value of $109618.0 for FY2023, which is 8501.11% down from last year.
  • According to the latest figures from Q4 2023, Avalon GloboCare's Research & Development is -$542.0, which was down 10028.56% from $17810.0 recorded in Q2 2023.
  • Avalon GloboCare's Research & Development's 5-year high stood at $949711.0 during Q2 2019, with a 5-year trough of -$542.0 in Q4 2023.
  • For the 5-year period, Avalon GloboCare's Research & Development averaged around $238509.4, with its median value being $213188.0 (2021).
  • In the last 5 years, Avalon GloboCare's Research & Development soared by 36100684.41% in 2019 and then tumbled by 10028.56% in 2023.
  • Over the past 5 years, Avalon GloboCare's Research & Development (Quarter) stood at $414559.0 in 2019, then crashed by 49.6% to $208920.0 in 2020, then soared by 67.03% to $348956.0 in 2021, then plummeted by 45.62% to $189762.0 in 2022, then crashed by 100.29% to -$542.0 in 2023.
  • Its Research & Development was -$542.0 in Q4 2023, compared to $17810.0 in Q2 2023 and $92350.0 in Q1 2023.